FDA Issues Feline Anthelmintic Guidance to Advance International Veterinary Drug Development
June 27, 2026
June 27, 2026
WASHINGTON, June 27 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued final guidance outlining recommendations for feline anthelmintic studies supporting international veterinary drug approvals and reviews.
The guidance, announced in a notice published in the Federal Register, is Guidance for Industry (GFI) No. 113, Effectiveness of Anthelmintics: Specific Recommendations for Felines. It was developed through the International Cooper . . .
The guidance, announced in a notice published in the Federal Register, is Guidance for Industry (GFI) No. 113, Effectiveness of Anthelmintics: Specific Recommendations for Felines. It was developed through the International Cooper . . .